In summary, we have shown that anti-BAFFR antibody treatment in hyperlipidemic ApoE−/− mice not only prevented atherosclerosis development but also attenuated the progression of established atherosclerosis. This evidence concerns the gene TNFRSF13C and atherosclerosis.